Qtron Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Qtron Investments’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,447	Closed	-$248K	–	397
2020 Q4	$248K	Buy	+3,447	New	+$180K	0.07%	292

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Qtron Investments's BEAT Position: Q1 2021 in Review

Qtron Investments sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,447 shares — an estimated $248K sold.

Qtron Investments first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $248K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Qtron Investments reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Qtron Investments sold 3,447 BioTelemetry, Inc. shares in Q1 2021, an estimated $248K.
Qtron Investments first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Qtron Investments's BioTelemetry, Inc. position peaked at $248K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Qtron Investments's 13F filing for Q1 2021, filed 13 May 2021.